|
Match
|
Document |
Document Title |
|
|
6214362 |
Cosmetic pad for removing low tension substances and applying cosmetics
A multi-functional cosmetic pad (100) for either absorbing low tension substances from the skin or applying and smoothing new-makeup, comprising a porous low energy surface (110) and crease...
|
|
|
6214368 |
Bone substitution material and a method of its manufacture
The present invention provides a novel process for converting a standard inert amorphous calcium phosphate precipitate into highly reactive amorphous solids. The amorphous solids can be used to...
|
|
|
6214374 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Compositions, methods and devices for the transdermal delivery of drugs
The present invention is directed to compositions, and methods for the delivery of drugs. Devices for the transdermal delivery of drugs are also provided. Specifically, the present invention...
|
|
|
6210698 |
Suppository composition
|
|
|
6211146 |
60A protein-induced morphogenesis
Disclosed are methods of utilizing a morphogenically active fragment of 60A protein to induce tissue morphogenesis, including methods for increasing a progenitor cell population in a mammal,...
|
|
|
6207194 |
Pectin process and composition
A composition comprising a dry cationic pectin salt which when suspended in water swells to heat stable particles having a mean equivalent diameter greater than 100 micrometers. Food, cosmetic,...
|
|
|
6207718 |
Pharmaceutical compositions containing hedgehog protein
A composition of a hedgehog protein which includes as an additive cyclodextrin, a non-ionic detergent, an anionic saccharide and/or ionic salt containing zinc ions, magnesium ions, calcium ions...
|
|
|
6207192 |
Prolongation of chemical activity of flavorants and therapeutics with cetyl pyridinium chloride
Cetyl pyridinium chloride and other amphiphilic substances may be mixed with flavorants or therapeutics in accompaniment with such as bulking agents or sweeteners in order to prolong their duration...
|
|
|
6207193 |
Transdermal drug delivery system
There is disclosed a transdermal drug delivery system wherein a drug or therapeutic agent is encapsulated in a water soluble carbohydrate. The carbohydrate-encapsulated drug or therapeutic agent,...
|
|
|
6200605 |
Antiflatulent composition
An antiflatulent composition is disclosed which comprises a polysaccharide and a preservative. The composition is useful to control gas formation at the site of generation of flatulence.
|
|
|
6197329 |
Anti-nausea compositions and methods
The present disclosure is directed to novel nutritional anti-nausea compositions, anti-emetic compositions, and methods of using same. The compositions provide improved relief from nausea and/or...
|
|
|
6197342 |
Use of biologically active glass as a drug delivery system
This invention relates to a synthetic bone replacement material impregnated with drugs such as antibiotics and growth hormones, which facilitate and promote the regeneration of bone and/or soft...
|
|
|
6197330 |
System for the treatment of wounds
Devices and methods for enhancing the healing of wounds, especially chronic wounds (e.g., diabetic wounds), involving the use of keratinocytes are described. Keratinocytes are grown on a...
|
|
|
6194000 |
Analgesic immediate and controlled release pharmaceutical composition
Disclosed is a method for the therapeutic treatment of pain related to wind up in a human or animal. The method of the invention is practiced by administering to the subject an effective amount of...
|
|
|
6193985 |
Tocopherol compositions for delivery of biologically active agents
The present invention provides the use of a tocopherol or a derivative thereof as a solvent and/or emulsifier for substantially insoluble and sparingly soluble biologically active agents,...
|
|
|
6190699 |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
The present invention describes a surprising new and effective pharmaceutical composition comprising microparticles and a pharmaceutically acceptable carrier. In particular, the present invention...
|
|
|
6187842 |
Sugar compounds, gelling agents, gelling agent compositions processes for the preparation of them, and gel compositions
|
|
|
6187347 |
Composition for arresting the flow of blood and method
A composition and method of arresting the flow of blood and other protein containing body fluids flowing from an open wound and for promoting wound healing. In the method, a substantially anhydrous...
|
|
|
6183771 |
Transdermal compositions containing levosimendan
|
|
|
6179871 |
Means for cartilage repair
A method for repairing a defect in cartilage, comprising the provision of apertures in the cartilage by drilling holes at the base of the cartilage defect, which holes may enter the mesenchymal...
|
|
|
6165507 |
Slow-release pharmaceutical formulations containing mizolastine
A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet...
|
|
|
6162467 |
Sustained release compositions and a method of preparing pharmaceutical compositions
A process for the manufacture of particles comprises mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixture so as to form...
|
|
|
6156344 |
Method for improving blood compatibility of interpenetrating multicomponent polymer
The present invention provides a method for improving blood compatibility of interpenetrating multicomponent polymer by controlling various factors affecting phase separation such as composition...
|
|
|
6156345 |
Crosslinkable macromers bearing initiator groups
A crosslinkable macromer system that includes two or more polymer-pendent polymerizable groups and one or more polymer-pendent initiator groups. The polymerizable groups and the initiator group(s)...
|
|
|
6153221 |
Use of biogically active glass as a drug delivery system
This invention relates to a synthetic bone replacement material impregnated with drugs such as antibiotics and growth hormones, which facilitate and promote the regeneration of bone and/or soft...
|
|
|
6149939 |
Healthful dissolvable oral tablets, and mini-bars
Dissolvable oral tablets and mini-bars which contain healthful ingredients. The products contain a multitude of discrete, extruded sections containing different healthful ingredients. A wide...
|
|
|
6149924 |
Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
Increased production of skin lipids, increased barrier function, hydrogen peroxide neutralization, prevention of loss of the natural moisturizing factor from the stratum corneum and moisturization...
|
|
|
6143328 |
Sustained release compositions and a method of preparing pharmaceutical compositions
Sustained release pharmaceutical formulations containing morphine, or a pharmaceutically acceptable salt thereof, as active ingredient, suitable for administration on a once daily basis, are...
|
|
|
6143278 |
Topical application of opioid analgesic drugs such as morphine
The invention is directed to methods and pharmaceutical compositions for the topical administration of opioid analgesic drugs such as morphine. In particular, the invention relates to topical...
|
|
|
6139876 |
Gel with increased oxygen content
A gelatin with increased oxygen content for pharmaceutical, cosmetic and/or veterinary use. The gelatin comprises a gelling agent and a solvent, furthermore oxygen in a substantially even...
|
|
|
6129931 |
Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
A pH-dependent, controlled-release, drug delivery composition is described herein which includes: (a) a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone, or their...
|
|
|
6126971 |
Stable oral CI-981 formulation and process for preparing same
An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981...
|
|
|
6124103 |
Arrangement and method of examining hydrophilic macromolecules in an aqueous solution
An arrangement for the investigation of hydrophilic macromolecules (1) in an aqueous solution having a solid carrier surface (5) onto which a lipid film (24) is disposed, wherein the molecules (1)...
|
|
|
6124355 |
Oxybutynin therapy
A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
|
|
|
6117456 |
Methods and products related to the physical conversion of reactive amorphous calcium phosphate
The present invention provides a novel process for producing a calcium phosphate cement or filler which hardens in a temperature dependent fashion in association with an endothermic reaction. In...
|
|
|
6117419 |
Delivery system for oil soluble actives in cosmetic/personal care products
Described herein is a method for making a flake for use in a topical application. The flake is formed by contacting a liquid phase waxy material that may contain pigments, fragrance, plasticizer,...
|
|
|
6117425 |
Supplemented and unsupplemented tissue sealants, method of their production and use
This invention provides supplemented tissue sealants, methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one cytotoxin or cell proliferation...
|
|
|
6110473 |
Emulsion comprising a gelled anionic hydrocolloid aqueous outer phase, a non-aqueous intermediate phase and an aqueous inner phase
The invention relates to an emulsion comprising an aqueous gelled outer phase, a non-aqueous intermediate phase and an inner phase containing an active ingredient incompatible with the gelled outer...
|
|
|
6103261 |
Opioid formulations having extended controlled release
Solid controlled-release oral dosage forms comprising a therapeutically effective amount of an opioid analgesic or a salt thereof which provide an extended duration of pain relief of about 24...
|
|
|
6103269 |
Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
The invention relates to accurately meterable shaped articles, for example granules or pellets, containing hydrophilic macromolecules, active compounds and optionally further pharmaceutically...
|
|
|
6103264 |
Process for preparing a controlled release composition
A process for preparing a controlled release composition with a controlled release matrix and containing a pharmaceutically active ingredient, which comprises granulating the active ingredient with...
|
|
|
6103266 |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
The present invention relates to a non water-soluble pharmaceutical carrier gel which adheres to mucosal surfaces and body tissues upon application and forms a film, providing protection and...
|
|
|
6099852 |
Wettable silicone-based lenses
This invention provide silicone-based, biomedical devices that exhibit improved wettability as well as biocompatability through the use of functional silane agents. More specifically, the invention...
|
|
|
6093389 |
Methods and compositions for attracting and controlling termites
The present invention provides a composition for attracting termites containing a steroid derivative of formula I ##STR1## The present invention also provides a method for attracting or controlling...
|
|
|
6090399 |
Controlled release composition incorporating metal oxide glass comprising biologically active compound
Disclosed are compositions containing biologically active compounds that slowly release the biologically active compound. These compositions may be directly incorporated into the locus to be...
|
|
|
6090368 |
Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
A pharmaceutical composition of a water soluble drug admixed with an aqueous bioadhesive cellulosic polymer containing microcrystalline particles. When sprayed (via a conventional spray device)...
|
|
|
6083534 |
Pharmaceutical compositions for controlled release of soluble receptors
A controlled release pharmaceutical composition includes a biocompatible polymeric material, preferably polyethylene-vinyl acetate or poly(lactic-glucolic acid), having incorporated therein a...
|
|
|
6083529 |
Liposome encapsulated active agent dry powder composition
A stable dry powder skin care powder having prolonged and controlled release properties, useful as baby powders, body talcs, deodorizing powders, OTC eczema preparations, foot powders, anti-fungal...
|
|
|
6083518 |
Composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
A biologically active composition comprising a solution of an active agent dissolved in a glass-forming carrier, which carrier comprises a glass-forming substance (A) containing a plasticizer (B),...
|
|
|
6080416 |
Low tack lotion, gels and creams
The present invention relates to a mixture of a silicone wax, a silicone fluid and two long chain lactate molecules which is effective in reducing the tacky feel of compositions. The present...
|